Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Altus dissolved

This article was originally published in The Tan Sheet

Executive Summary

Novartis, Quaker discussing future of products and assets in functional foods joint venture whose operations ceased at end of 2001, Quaker says. The 50/50 joint venture, housed in Quaker's Chicago offices, was formed in February 2000 with initial intent of marketing functional foods targeting health concerns of women, athletes and elderly. In 2001, Altus test-marketed Quaker Take Heart cereals, snack bars, juices in New York state and Women's Individual Nutrition cereals, snack bars, smoothies in Colorado. Novartis says joint venture termination was discussed and agreed upon when PepsiCo acquired Quaker Oats last year. Dissolution also reflects Novartis' move away from functional foods; in February, firm announced plans to divest its health and functional foods unit (1"The Tan Sheet" Feb. 11, 2002, p. 12)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093653

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel